{"abdominal tenderness": 3.46, "acute graft versus host disease": 5.14, "acute graft versus host disease in skin": 5.29, "acute kidney injury": 2.61, "acute lymphocytic leukaemia": 25.9, "acute lymphocytic leukaemia recurrent": 32.88, "acute myeloid leukaemia": 24.0, "acute myeloid leukaemia recurrent": 201.84, "acute promyelocytic leukaemia": 27.68, "acute respiratory distress syndrome": 6.25, "acute respiratory failure": 2.17, "adenovirus infection": 7.44, "agranulocytosis": 7.01, "alanine aminotransferase increased": 2.29, "alpha haemolytic streptococcal infection": 44.03, "anaemia": 2.43, "aplastic anaemia": 6.1, "appendicitis": 4.08, "ascites": 2.71, "aspergillus infection": 16.2, "atelectasis": 3.45, "b-cell lymphoma recurrent": 52.15, "bacteraemia": 17.18, "bacterial infection": 11.39, "bacterial sepsis": 14.43, "bk virus infection": 5.89, "blast crisis in myelogenous leukaemia": 11.83, "blood bilirubin increased": 3.11, "blood culture positive": 15.19, "blood disorder": 11.95, "blood lactate dehydrogenase increased": 10.7, "bone marrow failure": 22.03, "brain oedema": 2.14, "bronchopulmonary aspergillosis": 19.82, "burkitt's lymphoma": 39.38, "c-reactive protein increased": 2.29, "candida infection": 6.34, "cardiomyopathy": 5.04, "cardiotoxicity": 17.21, "central nervous system lymphoma": 58.87, "chloroma": 40.27, "cholestasis": 2.54, "chronic graft versus host disease": 3.88, "chronic myeloid leukaemia": 3.09, "clostridium difficile colitis": 9.1, "clostridium difficile infection": 6.12, "coagulopathy": 3.08, "colitis": 3.61, "congenital aplasia": 22.8, "cystitis haemorrhagic": 8.61, "cytogenetic abnormality": 44.03, "cytokine release syndrome": 2.85, "cytomegalovirus chorioretinitis": 22.43, "cytomegalovirus infection": 5.41, "cytomegalovirus infection reactivation": 10.14, "cytomegalovirus viraemia": 5.05, "cytopenia": 20.12, "device related infection": 2.7, "device related sepsis": 12.54, "differentiation syndrome": 32.17, "diffuse large b-cell lymphoma": 27.63, "diffuse large b-cell lymphoma recurrent": 128.5, "diffuse large b-cell lymphoma refractory": 136.96, "disease progression": 12.23, "disease recurrence": 4.81, "disseminated intravascular coagulation": 6.45, "drug resistance": 3.63, "drug-induced liver injury": 2.81, "encephalitis": 2.02, "encephalopathy": 3.19, "enteritis": 3.11, "enterobacter infection": 52.73, "enterococcal infection": 12.42, "enterovirus infection": 44.44, "escherichia bacteraemia": 30.89, "escherichia infection": 15.21, "escherichia sepsis": 15.23, "febrile bone marrow aplasia": 22.91, "febrile neutropenia": 46.23, "foetal growth restriction": 3.71, "follicular lymphoma": 21.24, "full blood count decreased": 4.59, "fungaemia": 30.34, "fungal infection": 7.73, "fusarium infection": 34.32, "gastrointestinal inflammation": 6.97, "gene mutation": 8.98, "geotrichum infection": 195.5, "graft versus host disease": 5.91, "granulocyte count decreased": 19.55, "granulocytopenia": 21.8, "haematotoxicity": 9.45, "haemoglobin abnormal": 19.86, "haemoglobin decreased": 3.29, "haemophagocytic lymphohistiocytosis": 9.33, "hepatic failure": 2.3, "hepatic function abnormal": 2.32, "hepatitis b": 4.27, "hepatitis b reactivation": 4.76, "hepatomegaly": 3.23, "hepatosplenomegaly": 6.15, "hepatotoxicity": 2.36, "herpes simplex": 2.82, "human herpesvirus 6 infection": 20.07, "human herpesvirus 6 infection reactivation": 45.94, "hydronephrosis": 4.0, "hyperbilirubinaemia": 9.27, "hypercalcaemia": 2.52, "hypertransaminasaemia": 3.26, "hypertriglyceridaemia": 2.28, "hypoalbuminaemia": 3.71, "hypogammaglobulinaemia": 21.43, "hypokalaemia": 2.86, "hypoxia": 3.31, "ileus": 3.12, "ill-defined disorder": 2.95, "immune effector cell-associated neurotoxicity syndrome": 2.27, "immunodeficiency": 2.04, "inappropriate antidiuretic hormone secretion": 3.68, "infection": 6.21, "infection in an immunocompromised host": 62.28, "intentional product use issue": 2.19, "intestinal perforation": 2.29, "klebsiella infection": 14.02, "klebsiella sepsis": 29.15, "leukaemia": 4.39, "leukaemia recurrent": 31.52, "leukocytosis": 2.97, "leukoencephalopathy": 22.15, "leukopenia": 4.03, "liver injury": 2.8, "low birth weight baby": 2.97, "lung infiltration": 2.77, "lymphocyte count decreased": 2.75, "lymphoma": 5.01, "mantle cell lymphoma": 28.99, "mantle cell lymphoma recurrent": 77.2, "mental status changes": 2.08, "minimal residual disease": 31.18, "mucormycosis": 25.41, "mucosal inflammation": 18.36, "multiple organ dysfunction syndrome": 7.68, "myelodysplastic syndrome": 17.2, "myelopathy": 23.6, "myelosuppression": 32.38, "neoplasm": 3.78, "neoplasm progression": 2.77, "neoplasm recurrence": 18.51, "nephropathy toxic": 2.82, "nervous system disorder": 2.74, "neuropathy peripheral": 2.51, "neurotoxicity": 5.86, "neutropenia": 6.78, "neutropenic colitis": 53.56, "neutropenic infection": 55.44, "neutropenic sepsis": 26.34, "neutrophil count decreased": 6.33, "non-hodgkin's lymphoma": 13.75, "odynophagia": 2.28, "oesophagitis": 2.58, "off label use": 3.46, "pancytopenia": 11.48, "parainfluenzae virus infection": 33.14, "paraplegia": 5.82, "pathogen resistance": 3.32, "peripheral sensory neuropathy": 3.64, "platelet count decreased": 4.72, "platelet count increased": 2.89, "pleural effusion": 2.84, "pneumocystis jirovecii pneumonia": 5.75, "pneumonia": 2.3, "pneumonia cytomegaloviral": 15.08, "pneumonia fungal": 24.48, "posterior reversible encephalopathy syndrome": 12.45, "premature baby": 2.88, "premature delivery": 9.91, "product use in unapproved indication": 5.36, "progressive multifocal leukoencephalopathy": 4.84, "pseudomonal sepsis": 14.57, "pseudomonas infection": 11.57, "pulmonary haemorrhage": 5.4, "pulmonary mass": 2.84, "refractory cancer": 148.31, "respiratory failure": 3.71, "rhinovirus infection": 19.72, "second primary malignancy": 10.97, "sepsis": 8.07, "septic shock": 14.04, "sinus tachycardia": 3.48, "skin lesion": 2.13, "splenomegaly": 4.15, "staphylococcal bacteraemia": 14.0, "staphylococcal infection": 4.75, "staphylococcal sepsis": 13.16, "stenotrophomonas infection": 42.18, "stomatitis": 3.18, "streptococcal bacteraemia": 44.4, "streptococcal sepsis": 30.43, "systemic candida": 20.04, "therapeutic product effect incomplete": 4.05, "therapeutic response decreased": 2.51, "therapy non-responder": 5.69, "therapy partial responder": 9.53, "thrombocytopenia": 5.7, "toxicity to various agents": 3.19, "treatment failure": 2.76, "tumour lysis syndrome": 15.23, "varicella zoster virus infection": 5.77, "venoocclusive disease": 16.46, "venoocclusive liver disease": 23.41, "white blood cell count abnormal": 6.7, "white blood cell count decreased": 5.22, "white matter lesion": 18.0}